Eslicarbazepine Acetate is Used for managing partial-onset seizures and absence seizures in patients with epilepsy. It was first introduced by Sumitomo Pharma America Inc in its drug Aptiom on Nov 8, 2013. 8 different companies have introduced drugs containing Eslicarbazepine Acetate.

Eslicarbazepine Acetate Patents

Given below is the list of patents protecting Eslicarbazepine Acetate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Aptiom	US9750747	Treatments involving eslicarbazepine acetate or eslicarbazepine	Aug 24, 2032	Sumitomo Pharma Am
Aptiom	US8372431	Pharmaceutical composition comprising licarbazepine acetate	Apr 17, 2030	Sumitomo Pharma Am
Aptiom	US10912781	Pharmaceutical composition comprising licarbazepine acetate	Oct 23, 2028	Sumitomo Pharma Am
Aptiom	US9566244	Pharmaceutical composition comprising licarbazepine acetate	Oct 23, 2028	Sumitomo Pharma Am
Aptiom	US9763954	Therapeutical uses of eslicarbazepine	Sep 13, 2028	Sumitomo Pharma Am
Aptiom	US9206135	Asymmetric catalytic reduction of oxcarbazepine	Apr 21, 2026	Sumitomo Pharma Am
Aptiom	US9643929	Asymmetric catalytic reduction of oxcarbazepine	Apr 21, 2026	Sumitomo Pharma Am
Aptiom	US10675287	Methods of treatment of partial onset seizures using eslicarbazepine acetate	May 06, 2025 (Expired)	Sumitomo Pharma Am
Aptiom	US10695354	Methods of treatment of partial onset seizures using eslicarbazepine acetate	May 06, 2025 (Expired)	Sumitomo Pharma Am
Aptiom	US10702536	Methods of treatment of partial onset seizures using eslicarbazepine acetate	May 06, 2025 (Expired)	Sumitomo Pharma Am
Aptiom	US11364247	Methods of treatment of partial onset seizures using eslicarbazepine acetate	May 06, 2025 (Expired)	Sumitomo Pharma Am
Aptiom	US5753646	Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them	Jun 27, 2021 (Expired)	Sumitomo Pharma Am

Add above patents to watchlist

Eslicarbazepine Acetate's Family Patents

Full family tree

Eslicarbazepine Acetate Generic API Manufacturers

Several generic applications have been filed for Eslicarbazepine Acetate. The first generic version for Eslicarbazepine Acetate was by Dr Reddys Laboratories Ltd and was approved on Jun 29, 2021. And the latest generic version is by Jubilant Generics Ltd and was approved on Aug 4, 2025.

Given below is the list of companies who have filed for Eslicarbazepine Acetate generic, along with the locations of their manufacturing plants worldwide.